Meera B Chitlur MD
Pediatric Coagulation Disorder Hematology
Professor, Pediatrics, Wayne State University School of Medicine
Join to View Full Profile
3901 Beaubien StDetroit, MI 48201
Phone+1 313-745-5515
Fax+1 313-745-5432
Dr. Chitlur is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Children's Hospital of MichiganFellowship, Pediatric Hematology/Oncology, 2001 - 2005
Henry Ford Hospital/Wayne State UniversityResidency, Pediatrics, 1994 - 1997
Kempegowda Institute of Medical ScienceClass of 1992
Certifications & Licensure
MI State Medical License 1997 - 2028
American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- America’s best physician National Consumer Advisory Board, 2019-2023
- Top Doc Hour Magazine, 2019-2022
- Super Doctor SuperDoctors.com
Clinical Trials
- Personalized Prediction of Tolerance and Immunogenicity in Hemophilia Start of enrollment: 2012 Jun 01
Publications & Presentations
PubMed
- A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia A.Marcio A Almeida, Vincent P Diego, Kevin R Viel, Bernadette W Luu, Karin Haack
Genes and Immunity. 2025-04-22 - Navigating coagulation: Key markers in the first 24 hours of pediatric ECMO.Jan V Stevens, Katherine Regling, Elika Ridelman, Meera Chitlur, Michelle Veenstra
Perfusion. 2025-04-14 - Bone Health Screening in Persons With Bleeding Disorders: A Survey of United States Haemophilia Treatment Centres.Divyaswathi Citla-Sridhar, Sanjay Ahuja, Robert Sidonio, Meera Chitlur, Anjali Sharathkumar
Haemophilia. 2025-03-07
Abstracts/Posters
- On the Role of F8 Sequence Mismatch and Class-II Human Leukocyte Antigen Binding in the Development of Neutralizing Antibodies (Inhibitors) Directed Against Therapeuti...Meera B. Chitlur, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- An Update on rFVIIa Use in Females with Rare Bleeding Disorders61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Genetics of Factor VIII Inhibitor Development in Hemophilia Patients: Novel Statistical Approaches in the PATH Study2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Efficacy of an Extended Half-Life GlycoPEGylated rFVIII (N8-GP): Pooled Analysis of ABR (Results from Two Clinical Trials)2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
